- Timo grimmer is in the team - All endpoints of the clinical trial were reached I firmly believe that the drug works and that the CEO has done a good job no matter how much he is criticized.

The drug shows it works as is!

we have a drug, even many drugs, good for so many indications, to become a giant pharma, we are about to get billions in revenues.

$AVXL The improvements in the drug arm cannot be lucky. .

Our drug has no side effects.

I'm looking forward to seeing the long term AD data on ANVS and have the feeling it's going to end up being the best in class AD treatment as well.

Do not listen to any FUD this drug is the real deal.

$AVXL amazing to see the actual benefits to people and their families of this “miracle drug” as they call it

$AVXL Dr. Perry said we have a legendary drug which actually reverses AD and is safe unlike Adulhelm.

and the part I really liked was "Even if the drug is priced conservatively, Ardelyx appears to be an easy potential multi-bagger of several magnitudes if investors can hold on to it for a decade."

So they are just going to see if they can prescribe their current IBS drug to kids, awesome!

$ARDX IBS drug total rx (TRX)are steady and growing.

$ARDX This company is sitting on a mountain of great fundamentals.. 40++ medical patents ,,, 40+ more in application status 1 drug approved IBSRELA 1 drug almost aproved XPHOZAH a kidney drug that could pull an annual billion dollar + revenue.

$ARDX Most drugs do not peak until 5 years from launch and we are at 1m $ / week after 41 weeks!

Dilution to launch TWO global drugs is money well spent.

They just got approval for 1 drug from FDA and things are bot going well there..

Now we're getting all these new drugs that really work well."

$ARDX come on you this other drug going off and this one is way better what the hell is everybody thinking let’s goooooo

It is just because it works - better than any other adhd drug!!!

Not bad vs a 2 billion plus drug.

New treatments and product launches: The development and launch of new and innovative treatments for ADHD, such as extended-release formulations and combination products, is also driving market growth.

$KMPH I dub thee Azstarys a wonder drug.

What a great time to have an up and coming better drug.

Second, Pascoe has a choice of many, many drugs to pluck away for a song. Many!!!

But I see the drug shortage is helping new drugs across the board and Azstarys did better since it is better among all those, imo.

$KMPH we are, qualified, the best ADHD drug on the market; not perfect,

$KMPH Cash position is outstanding, helped by a very efficient burn rate, and pipeline is advancing with 2 drugs that will have significant events in Q3 2023, and sales royalties from Corium will start ramping up in Q1.